SYNOPSIS A Vickers M300 analyser has been introduced into a busy hospital laboratory; a profile of 13 biochemical tests is currently provided. Analytical performance has been assessed over one year of routine service operation, and mechanical performance has been assessed over two separate three-month periods. At its best, the M300 achieves high standards of precision and accuracy and has the advantage of unrivalled speed.
Introduction of a Vickers M300 analyser into the routine service of a hospital laboratory SYNOPSIS A Vickers M300 analyser has been introduced into a busy hospital laboratory; a profile of 13 biochemical tests is currently provided. Analytical performance has been assessed over one year of routine service operation, and mechanical performance has been assessed over two separate three-month periods. At its best, the M300 achieves high standards of precision and accuracy and has the advantage of unrivalled speed.
Enzyme assay methods are less satisfactory than the kinetic assays in current use. Random analytical errors occur and are difficult to detect. The restricted facilities of the integral processcontrol computer are inadequate for effective quality control.
The Vickers M300 analyser is a high-capacity, multichannel, discrete analysis system, designed to carry out up to 20 different chemical tests on each blood plasma sample, operating at a rate of 300 samples per hour. The main features of the analyser have been described, and its performance in a formal evaluation programme reported, by Bick et al (1973) .
One of these analysers has been installed at the Middlesex Hospital Medical School to provide a routine service to the Middlesex Hospital and its associated hospitals and district. Details of the installation and operation of this analyser are given in the preceding paper (Buckley-Sharp et al, 1976) .
The purpose of this paper is to report the tests used and the reasons for their selection, the methods used, and the evaluation of these methods in routine use over a period of one year (January to December 1974) . In addition, we report two surveys of the mechanical performance of the M300 analyser: the first, in association with other users and with the Department of Health and Social Security (DHSS), was concerned with causes for delays in processing samples; the second, on our own initiative, was concerned with lost results and the need to recalculate results.
Selection of Tests
A decision was made that a full range of tests would ' Requests for reprints to ALM Received for publication 30 September 1975 be provided from the outset instead of gradually working up to full capacity. This simplified liaison with clinical staff. Fifteen methods were selected for preliminary assessment of linearity, precision, and accuracy: these were sodium, potassium, chloride, urea, calcium, phosphate, total protein, albumin, total and direct-acting bilirubin, alkaline phosphatase, aspartate aminotransferase (AST; GOT), hydroxybutyrate dehydrogenase (HBD), cholesterol, and uric acid. After careful consideration, glucose was not included because it was felt that, since measurements are made on unpreserved, and usually non-fasting, samples, the information would be at best of limited usefulness and, at worst, dangerously misleading. The 15 tests were used during a pilot study of the routine service (Buckley-Sharp et al, 1976) . By the time the full service began for all wards, the profile had been reduced to 13 tests by omitting (a) the HBD on the grounds that this specific 'isoenzyme' was an unjustifiable expense in a general profile, and (b) the direct-acting bilirubin, since most total bilirubin results were normal, and the direct-acting result proved helpful in only a minority of the residual cases. The method initially used for AST (Vickers method 061) is quite unsuitable. The basic assumptions of that method do not hold at high levels of activity, resulting in high levels giving low or zero results. Details of the method which has been developed to overcome this difficulty (Buckley-Sharp, 1974) will be given elsewhere: it will report activities up to about 200 iu/l (at 35°C), with higher activities consistently flagged as outside the system's limits.
Methods
The phosphate method initially recommended used molybdenum-blue, but poor precision resulted from inconsistent dissolution of a protein precipitate. The present method, based on the liberation of dye from a molybdate-malachite green complex, has been substituted and has been reported elsewhere (Stevens and Yeomans, 1975) .
Other Methods
A creatinine method is currently being tested on channels 4a and 4b. At present its precision at low levels is not very satisfactory It is hoped that it may later be possible to include a bicarbonate (total CO2) assay in place of the chloride, but the cost of the proposed enzymatic method is currently prohibitive.
Methods for glucose using glucose oxidase (Vickers method 140), hydroxybutyrate dehydrogenase (modified from Vickers method 070 for lactate dehydrogenase), and for direct-acting bilirubin were all found suitable for routine use, if required.
Urine Analyses
Where, previously, equipment has been used for both serum and urine analyses, there is some difficulty in transferring the serum analyses to the M300 if the other equipment must be kept ready for urine analyses. After evaluating the relevant M300 methods, urine calcium and phosphate are routinely measured on the M300. Urine urea is not measured on the M300 due to the uncontrolled contribution of urine ammonia to the Berthelot reaction; urine sodium and potassium, often requested with urea, are more conveniently done on a separate flamephotometer. The experimental creatinine method is suitable for urine analyses but the poor precision at low levels rules out its use for clearance measurements. Urine uric acid is infrequently requested in our laboratory and is not done on the M300.
Quality Control Procedures
Calibration of the M300 involves using watercontaining vials (baseline) and assayed-serum vials with stated values for each channel (single-point calibration). This calibration is immediately followed by assayed-serum vials with various levels for each channel, to check accuracy and linearity.
Unassayed pooled horse serum is used to check drifts and to examine within-day precision. Five vials precede the patients' samples: five pairs of vials are scattered among the patients' samples; and five vials follow the patients' samples.
At random points during each run are placed (a) further accuracy-check samples identical with those used immediately after the main calibration (see above), and (b) accuracy-check samples submitted independently by the biochemist in charge of the laboratory (LRW).
After the run a statistical evaluation is made of the drift control samples, and the accuracy check results are entered to cumulative records and inspected.
Analytical Performance
In order to evaluate within-day precision, the laboratory records were extracted retrospectively and the results for the drift control samples scattered among the patients' samples were extracted onto punched cards. Records could not be traced for a few of the days over the period 2 January to 31 December 1974. Where, on a given day, a channel had not been reported due to unacceptable drift, those data were ignored. The collected data were analysed by analysis of variance (ANOVA) using the BREAKDOWN subprogram of the Statistical Package for the Social Sciences (SPSS) (Nie et al, 1970; Nie and Hull, 1972) 31 January 1975 . Losses were grouped into (a) total channel loss, where no results were produced for that channel in a run; (b) partial channel loss where results for that channel stopped at some point during a run; and (c) channels requiring re-calculation because of drift or a fault in the main calibration. The error rates varied widely by channel and are shown in table VI. Since sodium, potassium, and urea are guaranteed to be supplied in all circumstances, the loss rates show how much extra work was involved in supplying these results using other equipment. During this time there were many difficulties with flame stability, resulting in considerable drift of sodium and potassium. AST suffered from a reagent failure and later from a bad photometer. some work on true kinetic methods for the M300 is in progress at other centres. The M300 can be efficiently used for some urine analyses, thus freeing other equipment and staff. This applies particularly to calcium and phosphate. The M300 calcium method is linear up to 30 mg/dl (7-5 mmol/l), and most urine calcium assays can be done on neat urine; phosphate and creatinine assays on urine both require that dilutions be prepared.
Precision (both within-day and between-day) and accuracy are adequate, as judged over the whole of 1974, during which time the M300 was providing a full routine service. At its best the M300 is capable of performance equal to or superior to other multichannel analysers, and it has the advantage of un-rivalled speed; but there is room for further improvement. Some of the results for within-day precision in table Ila compare unfavourably with those of Bick et al (1973) . Their results were obtained by formal evaluation while ours are taken from 12 months of routine use. We have removed the effect of outlying 'bad' days (table Ilb) to show typical performance.
Alkaline phosphatase does not appear to be very precise, and there is a fairly consistent positive bias (z = + 4 8). Part of the difficulty with this channel is the range of activity which it is desired to measure. The computer's analog-to-digital converter (ADC) has 10-bit precision (1024 steps), each step corresponding to around 10 mV at the photometer. Photometers do not usually have better precision than twice to three times this level (SD 20-30 mV) so that to use more than about 500 steps is beyond the equipment's normal resolution. To avoid a number of plasma dilutions, our alkaline phosphatase method is set to give values up to about 100 KingArmstrong units/dl with one decimal place, ie, about 1000 steps. There is a compromise between precision and the direct measurement of high levels of activity.
Albumin has shown a consistent negative bias ever since the method was installed. As far as can be seen, the effect is to compute a result of about 90 % of the albumin stated by some other methods. While this is not entirely satisfactory, it is at least constant and precise. We have given our clinical users specific information on albumin levels as measured by our M300, including a nomogram for modifying the plasma calcium based on the concurrent albumin result.
Chloride showed some drift during the first half of the year but this has stabilized. Urea suffered from reagent problems also during the first half of the year. Sodium was reading slightly low during the first half of the year, but later there was a marked drift upwards to give the overall positive bias shown. Potassium has read slightly low throughout but this may be due purely to result truncation. The latter part of 1974 was marked by serious problems with the flame photometer.
Mechanical performance of the machine has improved with time, and major breakdowns are infrequent. Careful preventive maintenance is of the utmost importance. The high operating speed copes with delays since even a large workload can be quickly analysed once the fault is corrected. The results for analyses lost during runs (table VI) should not be taken too literally. They demonstrate the order of magnitude of the difficulties but there is a tendency for an individual channel to evolve a problem which then takes a variable time to settle, after which the channel performs well again.
There is total dependence on quality control checks to ensure that the machine has functioned satisfactorily and that there have been no systematic errors. It may be added that any serious random error involving individual channels for individual samples can be detected only by an experienced observer scanning the individual reports, and possibly not even then.
Since the analysis results for samples are printed during the run and the quality control checks can only be completed afterwards, any correction procedure which is then required on the basis of quality control data must lead to manual correction of reports. Such an arrangement is not compatible with the high workload needed to make the M300 effective. There are some facilities for reading the cassette tape, making corrections, and reprinting, but these are time-consuming. Separate computer power is needed for a more careful surveillance of the M300's operations; the present standard package is, however, suitable for the basic mechanical operations of the machine. Some users of M300 analysers have acquired enhanced configurations of the integral processor: we have made proposals for enhancements using a separate computer to bridge the missing functions on the present M300 to more general purpose laboratory data processing facilities.
